Thursday, December 16, 2021 11:23:21 AM
Histogen Announces $3.5 Million Private Placement
8:00 am ET December 16, 2021 (Globe Newswire)
"Histogen Inc. (NASDAQ: HSTO), a clinical-stage company focused on developing potential first-in-class restorative therapeutics that ignite the body's natural process to repair and maintain healthy biological function, announced today that it has entered into securities purchase agreements with certain institutional and accredited investors to issue, in a private placement, 8,235,297 shares of common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to an aggregate of 8,235,297 shares of common stock, at a purchase price of $0.425 per share of common stock (or pre-funded warrant) and associated warrant, for expected gross proceeds to Histogen of approximately $3.5 million, before deducting placement agent fees and other offering expenses payable by the Company. The warrants have an exercise price of $0.425 per share of common stock, will be exercisable commencing six months and one day following the date of issuance for a period of five and one-half years from the date of issuance.
H.C. Wainwright & Co. is acting as the exclusive placement agent for the private placement.
The closing of the private placement is expected to occur on or about December 20, 2021, subject to the satisfaction of customary closing conditions. The Company intends to use the net proceeds from the private placement for working capital and general corporate purposes."
Recent HSTO News
- Histogen Files for Voluntary Chapter 11 Protection to Facilitate Wind-Down, Maximize Share Offering • GlobeNewswire Inc. • 04/18/2024 09:29:15 PM
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 01/04/2024 06:21:25 PM
- Histogen Announces Second Adjournment of Special Meeting of Stockholders • GlobeNewswire Inc. • 12/14/2023 09:15:00 PM
- Histogen Announces Adjournment of Special Meeting of Stockholders • GlobeNewswire Inc. • 12/05/2023 09:05:00 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 11/16/2023 09:07:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/18/2023 08:05:05 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 10/04/2023 08:08:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2023 08:05:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2023 08:06:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2023 08:16:54 PM
- Histogen Announces Board Approval of Complete Liquidation and Dissolution • GlobeNewswire Inc. • 09/18/2023 08:05:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2023 08:05:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:26:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/05/2023 09:18:51 PM
- Histogen to Explore Strategic Alternatives • GlobeNewswire Inc. • 07/05/2023 08:05:00 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM